A multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analyses.

Trends were observed toward greater reductions in HbA 1c in participants with higher baseline HbA 1c or higher baseline BMI vs those with lower baseline HbA 1c or lower baseline BMI, but these did not reach statistical significance for either characteristic (Figure 1a,c ).

also in 111,027 other papers